EDTA (Whole Blood - Do not spin)

MEDICAL NOTES

RHD NIPT is a molecular blood group genotyping assay for the detection of the fetal RHD gene (RHD) in the plasma of RhD negative pregnant women. It is used to predict the fetal RhD phenotype (RhD-positive or RhD-negative) blood group) to allow targeted, rather than universal, antenatal RhD-immunoprophylaxis.
 
This test is currently only offered to Private patients who present with a Lifeblood NIPT for Fetal D request form signed by the requesting practitioner.
 
Gestation must be 15 weeks or greater
 
COLLECTION NOTES:
Collect samples only on Mondays - Wednesdays (excluding Public Holidays). Do not collect on Thursday or Friday.
 
Patient must complete the Medicare details on NIPT for Fetal D request form and sign the form at the time of specimen collection.

LABORATORY NOTES: 

Samples MUST arrive at referral laboratory within 72 hrs of collection

Forward sample and request form to RCH Blood Bank for review and approval prior to dispatch

Samples should be stored at 2-8°C and samples must be transported with a cold ice-brick.

 Samples can be sent to QLD via Lifeblood Melbourne Processing Centre if they are clearly labelled:
           URGENT
           Attention: Specimen Reception
           NIPT Samples for delivery to Red Cell Reference at Brisbane Processing Centre